Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
SimonMed Launches AI Platform to Boost Mammogram Follow-Ups
Imaging & Diagnostics SimonMed Launches AI Platform to Boost Mammogram Follow-Ups

When a mammogram flags a concern, the clock starts ticking on follow-up care that too often stalls in confusion, voicemail loops, and missed appointments that undermine early detection. That gap—by SimonMed’s estimate, missed by up to 30% of eligible patients—has become the target of a new

mHealth Cuts Burden, Builds Coping for Cancer Caregivers
Digital Health mHealth Cuts Burden, Builds Coping for Cancer Caregivers

Caregivers of older adults with cancer confront a moving target of medical tasks and emotional strains that rarely pause long enough for traditional support to keep pace, and the gap between what families must do and the help they receive has real consequences for patient stability and caregiver

Are We Aligning Policy on Obesity, Diet, and Imaging?
Imaging & Diagnostics Are We Aligning Policy on Obesity, Diet, and Imaging?

Across boardrooms, journals, and committee rooms, a quiet realignment has been reshaping how the country thinks about obesity, diet quality, and diagnostic imaging as interlocking levers of population health rather than siloed issues with fragmented fixes. The latest signals came from three fronts:

How Will CMS Telehealth Updates Impact Providers and Patients?
Digital Health How Will CMS Telehealth Updates Impact Providers and Patients?

In the wake of a significant 43-day government shutdown, telehealth services under Medicare faced unprecedented disruptions, leaving providers unpaid and patients grappling with access issues, sparking intense discussion among healthcare stakeholders about the sustainability of virtual care. With

How Can Streamlined Patient Visits Reduce EHR Burden?
Digital Health How Can Streamlined Patient Visits Reduce EHR Burden?

In the demanding landscape of modern healthcare, clinicians face an escalating challenge with Electronic Health Records (EHRs), a system designed to enhance documentation and data sharing but often resulting in significant time constraints, particularly during new patient visits. This

Vet Expert: Breakthrough in Feline Leukemia Virus Detection
Imaging & Diagnostics Vet Expert: Breakthrough in Feline Leukemia Virus Detection

In a world where feline health faces persistent threats from diseases like Feline Leukemia Virus (FeLV), a retrovirus notorious for causing severe conditions such as immunosuppression, anemia, and lymphoma, the arrival of a groundbreaking diagnostic tool offers new hope for veterinarians and cat

Overture Life Earns CE Mark for Automated IVF System
Infrastructure & Management Overture Life Earns CE Mark for Automated IVF System

In a world where millions of individuals face the heart-wrenching challenge of infertility, technological advancements in assisted reproductive technology (ART) are offering new rays of hope, and a Spain-based innovator is leading the charge. Overture Life has recently secured a coveted CE mark for

IVD Test Market to Reach $120B by 2035 with 3.4% CAGR
Imaging & Diagnostics IVD Test Market to Reach $120B by 2035 with 3.4% CAGR

In the ever-evolving landscape of global healthcare, the In Vitro Diagnostic (IVD) Test Market stands as a critical pillar, providing essential tools for detecting diseases, monitoring health conditions, and informing treatment strategies. These tests, conducted outside the human body using samples

Can Bipartisan PBM Reform Lower Drug Costs for Patients?
Regulatory & Compliance Can Bipartisan PBM Reform Lower Drug Costs for Patients?

I'm thrilled to sit down with James Maitland, a seasoned expert in healthcare policy and pharmaceutical regulation, with a deep focus on the complex world of pharmacy benefit managers (PBMs) and drug pricing reforms in the United States. With years of experience analyzing the intricacies of the

Global eHealth 2.0 Market Set to Reach $851.5B by 2034
Patient Care Global eHealth 2.0 Market Set to Reach $851.5B by 2034

Imagine a world where a patient in a remote village consults a top specialist halfway across the globe through a smartphone, or where real-time health data prevents a medical emergency before it even starts. This is the promise of eHealth 2.0, the next frontier in digital healthcare that’s

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later